RNAi Therapeutics

Pages

▼
Showing posts with label primary hyperoxaluria type I. Show all posts
Showing posts with label primary hyperoxaluria type I. Show all posts
Wednesday, May 13, 2015

Dicerna Keeps Searching for Its Identity

›
Dicerna Pharmaceuticals recent move from Watertown to Cambridge is symbolic for its continued search for a place in the RNAi Therapeutics ...
8 comments:
Monday, November 17, 2014

Dicerna Admits Defeat, Licenses LNP Tech from Tekmira

›
Show me the non-human primate data .  Robust evidence of gene knockdown in monkeys is a key requirement to gain confidence in a company’s ...
4 comments:
›
Home
View web version
Powered by Blogger.